Walton County teen graduates after beating rare, aggressive cancer
A Georgia teen who was diagnosed with cancer during her senior year of high school is celebrating a momentous milestone this week.
Aubrey Barnett, 17, graduated from Walnut Grove High School in Loganville on May 20, just five months after finishing chemotherapy and ringing the celebration bell at The Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta.
Walnut Grove Principal Lindsey Allen praised Aubrey's resilience and achievement in a statement to 'Good Morning America.'
'Aubrey Barnett's strength, courage, and uplifting spirit have inspired our entire school community,' Allen said. 'Her victory over cancer while continuing to excel as a student is a powerful reminder of what determination and hope can accomplish. We are very proud of her!'
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
Aubrey told 'GMA' she first noticed a lump on her neck last summer but never thought it would turn out to be cancer. At the time, she was leading a busy life, running cross country and track, cheering for her school and working, as well as embarking on her final year in high school.
On Sept. 16, 2024, Aubrey received a life-changing diagnosis and learned she had Burkitt lymphoma, a rare and aggressive non-Hodgkin B-cell lymphoma that can cause rapid tumor growth in the head, neck, central nervous system and other areas of the body, according to StatPearls, an online library published in the National Library of Medicine, and the National Organization for Rare Disorders.
'I didn't really believe it,' Aubrey said. 'I was just living a normal life. I was like, there's no way I have cancer. I'm fine. And then when they told me, I was like, 'Are y'all serious?' Like, I didn't really know what to feel.'
Chancey Barnett, Aubrey's mom, said it was 'heart-wrenching' to hear her daughter had cancer.
'It went from an unnoticeable little lump to the size of her jaw. And so, it was obviously something,' Barnett said. 'It was just heart-wrenching to hear when they told us what it was. But just looking at her, I knew that it was going to be fine, because she's such a fighter, and she's so strong. I knew she'd be OK.'
MORE GRADUATION STORIES:
Rain didn't stop Emory graduates from celebrating special day
Commencement speaker donates $100K during Morris Brown College ceremony
Perfect attendance! Westlake High School graduate never missed a day of school
For three months, Aubrey underwent intensive chemotherapy, an aggressive treatment that included injections into the spinal cord, which caused her to have mouth sores and lose all of her hair.
'She had mouth sores so bad that she couldn't open her mouth because they were around her mouth, throughout her mouth, and down her esophagus,' Barnett explained. 'It was hard for her to eat, it was hard for her to talk, it was hard for her to do anything.'
Despite the difficult treatment, Aubrey never gave up, and her fellow classmates even voted her to be their homecoming queen while she was in the hospital.
Aubrey is now in remission and plans on attending Emmanuel University in the fall, where she will continue running cross country and track. She said she plans to major in exercise science to become a pediatric physical therapist.
Chancey Barnett said her daughter's cancer fight has changed everything for her and her family, but it's also proof of Aubrey's unshakeable will and strength.
'It was just a never-ending up-and-down battle. But she made it through all of it,' the mom of three said. 'When she says she's going to do something, she does it.'
For Aubrey, her message to anyone facing a challenge is to look for the positive whenever possible.
'Whatever you're going through, you can get through it if your mindset is right,' she said. 'I feel like that's the biggest thing is to have a good mindset, because if you just think about all the negatives, you're never going to be able to get through it. So you just need to think about the positives and that everything happens for a reason.'
[SIGN UP: WSB-TV Daily Headlines Newsletter]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Botulism cases linked to Botox injections under investigation in Massachusetts
Massachusetts health officials are investigating four recent cases of suspected botulism connected to cosmetic injections of Botox. The outbreak on the South Shore prompted the Department of Public Health to warn health care providers to be alert about symptoms. consistent with botulism occurring after botulinum toxin injections. Botox is widely used for cosmetic purposes to reduce wrinkles and fine lines. 'While generally safe when administered by trained professionals, improper dosing, administration technique, or use of non-FDA-approved products may increase the risk of systemic botulism symptoms,' the DPH advisory said. Botulism, though rare, can be fatal. It occurs when botulinum toxin enters the bloodstream and can produce effects far from the injection site, according to the advisory. Initial botulism symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing and breathing problems, according to state health officials. These symptoms may progress to muscle weakness that worsens over hours to days. Anybody who is experiencing any symptoms should go to an emergency room. 'This is very rare,' South Shore Hospital infectious disease specialist Dr. Todd Ellerin told WCVB. 'We call it iatrogenic botulism, which means you get it as a complication of an injection. It is very rare.' The DPH has not released details about the condition of the four individuals involved in the South Shore cases or information about the provider or facility where they received their injections. How pink heart shaped fentanyl led to Mass. father's 18-year prison sentence ICE deportation blocked by Boston judge: Migrants now in shipping container in Djibouti Mass. State Lottery winner: Father will take children to Disney with $100K prize Former police deputy chief, school resource officer convicted of child rape Mass. casino winner: $2.50 bet won gambler jackpot prize ``` Read the original article on MassLive.
Yahoo
2 days ago
- Yahoo
EMA says Ozempic, Wegovy may cause rare eye condition
-- The European Medicines Agency's (EMA) safety committee, PRAC, said Friday that it has concluded that Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition that can lead to vision loss, is a "very rare side effect" of semaglutide medicines, including Ozempic, Rybelsus, and Wegovy. The medications, owned by Novo Nordisk (NYSE:NVO), are widely used for the treatment of diabetes and obesity. Following a comprehensive review of all available data, including non-clinical studies, clinical trials, post-marketing surveillance, and medical literature, PRAC determined that NAION "may affect up to 1 in 10,000 people taking semaglutide." The firm explained that several large epidemiological studies indicate that adults with type 2 diabetes taking semaglutide face "an approximately two-fold increase in the risk of developing NAION" compared to those not on the medication. This is said to translate to about "one additional case of NAION per 10,000 person-years of treatment." The EMA added that clinical trial data also pointed to a "slightly higher risk" for those on semaglutide versus placebo. As a result, the EMA said it has recommended updating the product information for semaglutide medicines to include NAION as a "very rare" side effect. They conclude that patients experiencing "a sudden loss of vision or rapidly worsening eyesight" while on semaglutide are advised to contact their doctor immediately. If NAION is confirmed, "treatment with semaglutide should be stopped,' states the EMA. Related articles EMA says Ozempic, Wegovy may cause rare eye condition Virgin Galactic stock jumps on SpaceX competition speculation Vera Therapeutics stock sinks following competitor's successful trial
Yahoo
3 days ago
- Yahoo
Cancer Risk at Air Force Missiles Sites Low 'But Not Zero,' Latest Service Data Shows
Airmen who watched over America's nuclear intercontinental ballistic missiles in Cold War-era facilities faced marginally higher risk of cancer due to contaminants found there and more workplace oversight is needed, according to the latest findings of an Air Force health study. Air Force Global Strike Command, during a town hall event Wednesday, released the latest data showing the slightly elevated cancer risk as part of its ongoing probe into health concerns for America's missileers, maintainers and other support roles at several bases in the Midwest and Western U.S. The lifetime cancer risk for all Americans is around 39%, and the Air Force's Health Risk Assessment found rates of 39.9% to 40.13% for men and women if they would have served anywhere from eight to 70 years in those jobs. Service officials said consistent workplace inspections and monitoring would likely be necessary to address the risks, which are caused by the presence of chemicals and toxins. Read Next: Army Faces Backlash over Plan to Divert Barracks Funds to Border Mission Contaminants linked to cancer were found during a series of environmental studies at F.E. Warren Air Force Base in Wyoming, Malmstrom Air Force Base in Montana, and Minot Air Force Base in North Dakota. "In summary, this health risk assessment characterizes the health risk as low but not zero," Col. Ric Speakman, the commander of the U.S. Air Force School of Aerospace Medicine, said during the town hall presentation. "Therefore, the appropriate action is to include missile alert facility workers in an occupational surveillance." Air Force Global Strike Command is still in the process of an ongoing epidemiological study and is gathering more data from states as well as national cancer registries before more definitive cancer and health conclusions can be made. Last year, reported in an investigative series that past probes by the Air Force into cancer concerns roughly two decades ago went ignored, and past and current missileers and nuclear missile maintainers raised alarms about the environmental conditions, toxins and chemical dangers they faced while in uniform. They believe the conditions made them sick. In the wake of reporting, the service announced changes that included new workplace inspections and health record tracking, and the spouse of a missileer who died from non-Hodgkin lymphoma was able to secure Department of Veterans Affairs benefits related to his death. While polychlorinated biphenyls, or PCBs, were one of the known outlawed carcinogenes that the Air Force's remediation efforts focused on, research shown during Wednesday's town hall showed there were other toxins detected as well that were factored into the service's health risk assessment. "Although only PCBs were detected at levels above the Environmental Protection Agency's standards for cleanup and remediation, the environmental sampling was sensitive enough to detect chemicals such as benzene and chloroform at levels well below standards for remediation," a Thursday news release from Air Force Global Strike Command following the town hall said. The Torchlight Initiative, a grassroots organization that began shortly after a Space Force officer and former Air Force missileer raised concerns about non-Hodgkin lymphoma rates at Malmstrom, released its own independent study in April examining the rates of blood cancer reported in its online health registry. That study found that service members were diagnosed at younger ages compared to the wider population. Air Force Global Strike Command officials briefly mentioned that study at the town hall, stating that, "while this study is separate from the missile community cancer study, it does add to the work advocacy and the well-being of the missile community." Representatives from the Torchlight Initiative were on Capitol Hill in early April alongside other advocacy groups, and made a plea to lawmakers in hopes of expanding the PACT Act -- a 2022 law that mostly covered veterans sickened by toxic exposure in war zones -- to cover those who experienced health issues stateside as well. "The Torchlight Initiative is happy to hear that Global Strike and U.S. Air Force School of Aerospace Medicine are still working on their long-term study and research," the organization said in a statement to on Thursday. "However, our focus and energy remains with the families who are disproportionately affected by these cancers and illnesses." The remaining data in the ongoing health study is slated to be released in late 2025. Gen. Thomas Bussiere, the head of Air Force Global Strike Command, said during the town hall he would advocate for a registry, if the VA also supported such a move, based on the study's findings. "The level of interest and oversight with the Department of the Air Force and Congress has not waned, and I'm very thankful and happy with the interest and actions on the part of the VA," Bussiere said in a news release after the town hall. "They've been great partners, and I anticipate they will continue to be great partners." Related: Independent Study Raises Alarm About Non-Hodgkin Lymphoma at Malmstrom Air Force Base
